PortfoliosLab logo
CC vs. IOSP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CC and IOSP is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

CC vs. IOSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Chemours Company (CC) and Innospec Inc. (IOSP). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%NovemberDecember2025FebruaryMarchApril
6.90%
124.62%
CC
IOSP

Key characteristics

Sharpe Ratio

CC:

-0.90

IOSP:

-0.82

Sortino Ratio

CC:

-1.46

IOSP:

-1.09

Omega Ratio

CC:

0.83

IOSP:

0.86

Calmar Ratio

CC:

-0.66

IOSP:

-0.72

Martin Ratio

CC:

-1.48

IOSP:

-1.63

Ulcer Index

CC:

34.55%

IOSP:

16.00%

Daily Std Dev

CC:

56.80%

IOSP:

31.76%

Max Drawdown

CC:

-86.15%

IOSP:

-91.17%

Current Drawdown

CC:

-71.10%

IOSP:

-31.21%

Fundamentals

Market Cap

CC:

$1.86B

IOSP:

$2.27B

EPS

CC:

$0.57

IOSP:

$1.42

PE Ratio

CC:

21.70

IOSP:

63.23

PEG Ratio

CC:

1.67

IOSP:

-2.95

PS Ratio

CC:

0.32

IOSP:

1.23

PB Ratio

CC:

3.06

IOSP:

1.86

Total Revenue (TTM)

CC:

$4.43B

IOSP:

$1.35B

Gross Profit (TTM)

CC:

$866.00M

IOSP:

$387.20M

EBITDA (TTM)

CC:

$487.00M

IOSP:

$159.00M

Returns By Period

In the year-to-date period, CC achieves a -25.58% return, which is significantly lower than IOSP's -18.42% return.


CC

YTD

-25.58%

1M

-9.84%

6M

-30.45%

1Y

-52.30%

5Y*

6.04%

10Y*

N/A

IOSP

YTD

-18.42%

1M

-5.68%

6M

-17.22%

1Y

-24.93%

5Y*

5.32%

10Y*

8.85%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CC vs. IOSP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CC
The Risk-Adjusted Performance Rank of CC is 88
Overall Rank
The Sharpe Ratio Rank of CC is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of CC is 66
Sortino Ratio Rank
The Omega Ratio Rank of CC is 99
Omega Ratio Rank
The Calmar Ratio Rank of CC is 1111
Calmar Ratio Rank
The Martin Ratio Rank of CC is 99
Martin Ratio Rank

IOSP
The Risk-Adjusted Performance Rank of IOSP is 99
Overall Rank
The Sharpe Ratio Rank of IOSP is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of IOSP is 1212
Sortino Ratio Rank
The Omega Ratio Rank of IOSP is 1212
Omega Ratio Rank
The Calmar Ratio Rank of IOSP is 88
Calmar Ratio Rank
The Martin Ratio Rank of IOSP is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CC vs. IOSP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Chemours Company (CC) and Innospec Inc. (IOSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CC, currently valued at -0.90, compared to the broader market-2.00-1.000.001.002.003.00
CC: -0.90
IOSP: -0.82
The chart of Sortino ratio for CC, currently valued at -1.46, compared to the broader market-6.00-4.00-2.000.002.004.00
CC: -1.46
IOSP: -1.09
The chart of Omega ratio for CC, currently valued at 0.83, compared to the broader market0.501.001.502.00
CC: 0.83
IOSP: 0.86
The chart of Calmar ratio for CC, currently valued at -0.66, compared to the broader market0.001.002.003.004.005.00
CC: -0.66
IOSP: -0.72
The chart of Martin ratio for CC, currently valued at -1.48, compared to the broader market-5.000.005.0010.0015.0020.00
CC: -1.48
IOSP: -1.63

The current CC Sharpe Ratio is -0.90, which is comparable to the IOSP Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of CC and IOSP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.90
-0.82
CC
IOSP

Dividends

CC vs. IOSP - Dividend Comparison

CC's dividend yield for the trailing twelve months is around 8.08%, more than IOSP's 1.73% yield.


TTM20242023202220212020201920182017201620152014
CC
The Chemours Company
8.08%5.92%3.17%3.27%2.98%4.03%5.53%2.98%0.24%0.54%10.82%0.00%
IOSP
Innospec Inc.
1.73%1.41%1.14%1.24%1.28%1.15%0.99%1.44%1.09%0.98%1.12%1.29%

Drawdowns

CC vs. IOSP - Drawdown Comparison

The maximum CC drawdown since its inception was -86.15%, smaller than the maximum IOSP drawdown of -91.17%. Use the drawdown chart below to compare losses from any high point for CC and IOSP. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-71.10%
-31.21%
CC
IOSP

Volatility

CC vs. IOSP - Volatility Comparison

The Chemours Company (CC) has a higher volatility of 32.93% compared to Innospec Inc. (IOSP) at 13.18%. This indicates that CC's price experiences larger fluctuations and is considered to be riskier than IOSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
32.93%
13.18%
CC
IOSP

Financials

CC vs. IOSP - Financials Comparison

This section allows you to compare key financial metrics between The Chemours Company and Innospec Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items